These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20519858)

  • 21. A 5-fluorouracil-loaded floating gastroretentive hollow microsphere: development, pharmacokinetic in rabbits, and biodistribution in tumor-bearing mice.
    Huang Y; Wei Y; Yang H; Pi C; Liu H; Ye Y; Zhao L
    Drug Des Devel Ther; 2016; 10():997-1008. PubMed ID: 27042001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
    Lai LF; Guo HX
    Int J Pharm; 2011 Feb; 404(1-2):317-23. PubMed ID: 21094232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactosaminated and intact N-succinyl-chitosans as drug carriers in liver metastasis.
    Kato Y; Onishi H; Machida Y
    Int J Pharm; 2001 Sep; 226(1-2):93-106. PubMed ID: 11532574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
    Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates.
    Kato Y; Onishi H; Machida Y
    Biomaterials; 2004 Feb; 25(5):907-15. PubMed ID: 14609679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
    Huang C; Li NM; Gao P; Yang S; Ning Q; Huang W; Li ZP; Ye PJ; Xiang L; He DX; Tan XW; Yu CY
    Drug Deliv; 2017 Nov; 24(1):459-466. PubMed ID: 28219253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermosensitive hydrogel based on chitosan and its derivatives containing medicated nanoparticles for transcorneal administration of 5-fluorouracil.
    Fabiano A; Bizzarri R; Zambito Y
    Int J Nanomedicine; 2017; 12():633-643. PubMed ID: 28144144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption and distribution characteristics of 5-fluorouracil (5-FU) after an application to the liver surface in rats in order to reduce systemic side effects.
    Kodama Y; Fumoto S; Nishi J; Nakashima M; Sasaki H; Nakamura J; Nishida K
    Biol Pharm Bull; 2008 May; 31(5):1049-52. PubMed ID: 18451546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
    Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
    J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
    Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
    PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice.
    Zheng N; Zhou M; Lu W
    Eur J Drug Metab Pharmacokinet; 2013 Sep; 38(3):183-90. PubMed ID: 23179563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
    Sharma A; Kaur A; Jain UK; Chandra R; Madan J
    Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study.
    Choi SJ; Oh JM; Choy JH
    J Nanosci Nanotechnol; 2010 Apr; 10(4):2913-6. PubMed ID: 20355523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of succinyl chitosan and succinyl chitosan nanoparticle film: In vitro and in vivo evaluation of wound healing activity.
    Thao NTT; Wijerathna HMSM; Kumar RS; Choi D; Dananjaya SHS; Attanayake AP
    Int J Biol Macromol; 2021 Dec; 193(Pt B):1823-1834. PubMed ID: 34785202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].
    Huang KH; Liu JH; Zhu ZH; Li XX; Lu XP; Zhou SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1137-40. PubMed ID: 17715009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of magnetic nanoparticles coated by 5-fluorouracil imprinted polymer for controlled drug delivery in mouse breast cancer model.
    Hashemi-Moghaddam H; Kazemi-Bagsangani S; Jamili M; Zavareh S
    Int J Pharm; 2016 Jan; 497(1-2):228-38. PubMed ID: 26621688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.